Bio-implants market report covers landscape and
its growth prospects over the coming years, the Report also brief deals with
the product life cycle, comparing it to the relevant products from across
industries that had already been commercialized details the potential for
various applications, discussing about recent product innovations and gives an
overview on potential regional market shares.
Bio-implants Market is anticipated to garner $115.8 billion by 2020, registering a CAGR of 10.3% during the forecast period. Cardiovascular bio implants would garner sizable share among other segments, accounting for 30% of total market throughout the forecast period.
Bio-implants Market is anticipated to garner $115.8 billion by 2020, registering a CAGR of 10.3% during the forecast period. Cardiovascular bio implants would garner sizable share among other segments, accounting for 30% of total market throughout the forecast period.
Additionally, the orthopedic and dental bio implants are forecast to have a promising growth rate. High prevalence of disease conditions such as cardiovascular, orthopedic and spinal disorders that are amenable to treatment via bio implants is the prime driver of the bio implants market.
For instance, cardiovascular diseases prevalence is expected to exceed ~12 million by 2020. 30% of such cardiovascular patient population are amenable to treatment via bio implants; analogous factors exist in context of orthopedic, spinal and other disorders.
Get Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/576
Key players operating in the bio-implants market focus on product launch, and continual R&D on variants of the market in order to retain competitive advantage. These players also adopt inorganic growth strategy to augment geographical diversification.
Few of such companies mentioned in the report are:
• DENTSPLY International
• Wright Medical group
• Invibio Biomaterial Solutions
• Biomet (Zimmer)
• Medtronic
• Stryker Corporation
• Smith & Nephews
• DePuy Synthes
• Ethicon Inc.
• KLS martin
Also, development of variants of bio/raw materials that enhance biocompatibility of bio implants (products) is expected to drive the market growth. Advanced technologies such as 3D printing, laser and nanotechnology deployed for manufacturing bio implants also significantly enhance biocompatibility of bio implants; therefore, it is expected to be another key driver for the global bio implants market.
The global bio-implants market is segmented based on product types and geography. Within the product types, the market is segmented into cardiovascular, dental and prosthetic implants, orthopedic/joint reconstruction and replacement, spinal, ophthalmology and others. Geographically, the market is segmented into four regions, namely North America, Europe, Asia-Pacific and LAMEA.
Make Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/576
Key findings of Bio-Implants Market:
• Cardiovascular, orthopedic and dental bio implants collectively garner about 70% market share of the global market
• Dental bio implants segment market is expected to be a key high-growth market with about 14% CAGR over 2014 - 2020
• Orthopedic bio implants are expected to be the second largest market segment (in terms of value) owing to rising occurrence of accidents and other such incidents that result in fractures, necessitating treatment via bio implants
• Lifestyle diseases, prominently the cardiovascular diseases can be treated and further post-operatively rehabilitated by usage of bio implants, namely pacemakers/stents/valves; therefore, rising incidence of such disorders is expected to render high growth rate and large market size in terms of value by 2020 for cardiovascular bio implants
Access the latest trends and insights: https://www.alliedmarketresearch.com/bio-implants-market
No comments:
Post a Comment